Network pharmacology and experimental validation to explore the effects and mechanisms of flavonoids luteolin and chrysoeriol against non‑small cell lung cancer | Synapse
March 3, 2026
Network pharmacology and experimental validation to explore the effects and mechanisms of flavonoids luteolin and chrysoeriol against non‑small cell lung cancer
Puntos clave
Luteolin and chrysoeriol show significant effects on inhibiting non-small cell lung cancer growth, enhancing treatment options.
In vitro studies reveal that flavonoids cause a decrease in tumor cell proliferation by modulating specific pathways.
Network pharmacology analysis highlights potential mechanisms of action, guiding future experiments and treatments.
Findings suggest that flavonoids could offer new avenues for therapeutic intervention, needing further exploration.